Quick Answer
Axogen, Inc. reported Research And Development Expense of $32.89 million for the year ending 2025.
- Axogen, Inc. showed an increase of +18.4% in Research And Development Expense from 2024 to 2025.
- This data is from Axogen, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), Axogen, Inc.'s Research And Development Expense has grown by 7,442.3%.
- Historical annual values: Fiscal year 2025: $32.89 million | Fiscal year 2024: $27.77 million | Fiscal year 2023: $27.34 million | Fiscal year 2022: $25.63 million | Fiscal year 2021: $24.18 million | Fiscal year 2020: $17.85 million | Fiscal year 2019: $17.51 million | Fiscal year 2018: $11.77 million | Fiscal year 2017: $6.70 million | Fiscal year 2016: $4.21 million | Fiscal year 2015: $3.24 million | Fiscal year 2014: $3.03 million | Fiscal year 2013: $2.13 million | Fiscal year 2012: $1.43 million | Fiscal year 2011: $697.4 thousand | Fiscal year 2010: $436.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: